<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03361618</url>
  </required_header>
  <id_info>
    <org_study_id>Babil-5</org_study_id>
    <nct_id>NCT03361618</nct_id>
  </id_info>
  <brief_title>Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway</brief_title>
  <official_title>Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway in Spermatozoa and Seminal Plasma of Iraqi Asthenospermic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Babylon University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Iraq</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Babylon University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although many reports have investigated the relationship between subfertility and uric acid
      levels in semen, to the best of author knowledge, there is no study have been published to
      yet focus on the effects of asthenospermia treatments, such as given an oral zinc
      supplementation, on the activity of urate-related enzymes, which are important in fertility
      of human.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study was designed to investigate the effect of zinc supplementation on the
      qualitative and quantitative characteristics of semen, along with uric acid levels and
      urate-related enzymes in the seminal plasma and spermatozoa of asthenospermic males.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2011</start_date>
  <completion_date type="Actual">June 1, 2012</completion_date>
  <primary_completion_date type="Actual">June 1, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Semen volume after treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement the uric acid level in spermatozoa and seminal plasma by using spectrophotometer.</measure>
    <time_frame>up to three months.</time_frame>
    <description>Clinical parameter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement the adenosine deaminase activity in spermatozoa and seminal plasma by using spectrophotometer.</measure>
    <time_frame>up to three months.</time_frame>
    <description>Enzyme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement the xanthine oxidase activity in spermatozoa and seminal plasma by using spectrophotometer.</measure>
    <time_frame>up to three months.</time_frame>
    <description>Enzyme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement the 5'-nucleotidase activity in spermatozoa and seminal plasmaby using the spectrophotometer.</measure>
    <time_frame>up to three months.</time_frame>
    <description>Enzyme</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Infertility Unexplained</condition>
  <arm_group>
    <arm_group_label>Zinc sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 subfertile (age 32.5±3.23 year) men with asthenozoospermia was treated with zinc sulfate, every participant took two capsules of zinc sulfate per day for three months (each one 220 mg).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>60 fertile (age 31.6±3.3 year) men, no treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc Sulfate</intervention_name>
    <description>The subfertile group treated with zinc sulfate, every participant took two capsules of zinc sulfate per day for three months (each one 220 mg).</description>
    <arm_group_label>Zinc sulfate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The presence of asthenozoospermia in the semen sample.

          -  Must be unable to reproduce.

        Exclusion Criteria:

          -  the absence of endocrinopathy, varicocele, and female factor infertility. Smokers and
             alcoholic men were excluded from the study because of their recognized high seminal
             ROS levels and decreased antioxidant levels.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male that undergo the presence of asthenozoospermia in the semen sample.</gender_description>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdul Razzaq A. Alsalman, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Babyblon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lamia A. Almashhedy, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Babyblon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahmoud Hussein Hadwan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Babyblon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdulsamie H Alta'ee, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Babyblon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahmoud Hussein Hadwan</name>
      <address>
        <city>Hilla</city>
        <state>Babylon</state>
        <zip>51002</zip>
        <country>Iraq</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Babylon University</investigator_affiliation>
    <investigator_full_name>mahmoud hussein hadwan</investigator_full_name>
    <investigator_title>Principal Investigator Dr. Mahmoud Hussein Hadwan</investigator_title>
  </responsible_party>
  <keyword>Uric acid</keyword>
  <keyword>Adenosine deaminase</keyword>
  <keyword>Zinc Sulfate</keyword>
  <keyword>5'-nucleotidase</keyword>
  <keyword>Asthenospermia.</keyword>
  <keyword>Xanthine oxidase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

